Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cue Biopharma (CUE) Other Operating Expenses (2022 - 2025)

Historic Other Operating Expenses for Cue Biopharma (CUE) over the last 4 years, with Q3 2025 value amounting to $51000.0.

  • Cue Biopharma's Other Operating Expenses fell 4742.27% to $51000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $47000.0, marking a year-over-year increase of 17833.33%. This contributed to the annual value of $93000.0 for FY2024, which is 15923.57% up from last year.
  • Per Cue Biopharma's latest filing, its Other Operating Expenses stood at $51000.0 for Q3 2025, which was down 4742.27% from -$4000.0 recorded in Q4 2024.
  • In the past 5 years, Cue Biopharma's Other Operating Expenses ranged from a high of $97000.0 in Q3 2024 and a low of -$258000.0 during Q2 2022
  • Over the past 4 years, Cue Biopharma's median Other Operating Expenses value was -$11500.0 (recorded in 2022), while the average stood at -$48333.3.
  • In the last 5 years, Cue Biopharma's Other Operating Expenses crashed by 72631.58% in 2023 and then soared by 9745.22% in 2024.
  • Over the past 4 years, Cue Biopharma's Other Operating Expenses (Quarter) stood at -$19000.0 in 2022, then tumbled by 726.32% to -$157000.0 in 2023, then surged by 97.45% to -$4000.0 in 2024, then soared by 1375.0% to $51000.0 in 2025.
  • Its Other Operating Expenses stands at $51000.0 for Q3 2025, versus -$4000.0 for Q4 2024 and $97000.0 for Q3 2024.